Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Persistence Market Research | PRODUCT CODE: 1722151

Cover Image

PUBLISHER: Persistence Market Research | PRODUCT CODE: 1722151

Pain Relief Patches Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032

PUBLISHED:
PAGES: 250 Pages
DELIVERY TIME: 2-5 business days
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 4995
PDF & Excel (Multi User License)
USD 7295
PDF & Excel (Corporate User License)
USD 8495

Add to Cart

Persistence Market Research has recently released a comprehensive report on the global Pain Relief Patches Market, providing an in-depth analysis of key market dynamics, including driving forces, emerging trends, opportunities, and challenges. This report offers a detailed understanding of the market landscape, helping stakeholders make well-informed decisions.

Key Insights:

  • Pain Relief Patches Market Size (2025E): US$ 4.1 Bn
  • Projected Market Value (2032F): US$ 6 Bn
  • Global Market Growth Rate (CAGR 2025 to 2032): 5.7%

Pain Relief Patches Market - Report Scope:

The global pain relief patches market comprises transdermal products that deliver active pharmaceutical ingredients directly to the affected area to manage various forms of acute and chronic pain. These patches offer several advantages, including targeted delivery, reduced systemic side effects, and improved patient compliance. Commonly used for conditions such as musculoskeletal disorders, post-operative pain, neuropathic pain, and menstrual cramps, pain relief patches are witnessing increased demand due to the growing preference for non-invasive pain management solutions.

Market Growth Drivers:

The growth of the pain relief patches market is being driven by a rising global prevalence of chronic pain conditions such as arthritis, back pain, and neuropathy. The aging population, particularly in developed countries, is increasingly seeking effective pain management options, thereby fueling demand for convenient and long-lasting transdermal solutions. In addition, growing consumer awareness regarding the adverse effects of oral painkillers, including gastrointestinal issues and addiction risks, is encouraging a shift toward topical alternatives. The increasing adoption of self-care practices and over-the-counter availability of several pain relief patches are further supporting market growth. Technological advancements in transdermal drug delivery systems have also enhanced the efficacy and safety profiles of these patches, contributing to their rising adoption.

Market Restraints:

Despite promising growth prospects, the pain relief patches market faces several constraints. One of the primary limitations is the relatively high cost of branded transdermal patches compared to oral pain relievers, which may limit adoption in cost-sensitive markets. Additionally, the limited drug load capacity of patches and the slow onset of action in some formulations can restrict their use for severe or acute pain conditions. Regulatory challenges and variations in approval pathways across regions also hinder the swift launch and distribution of new products. Moreover, the presence of counterfeit and substandard patches in unregulated markets poses risks to patient safety and undermines consumer trust.

Market Opportunities:

The pain relief patches market presents ample opportunities for growth, particularly in emerging economies where healthcare infrastructure is rapidly expanding, and consumer spending on personal healthcare is increasing. There is significant potential for innovation in developing novel drug formulations and advanced transdermal technologies that offer controlled and sustained drug release. Collaborations between pharmaceutical companies and research institutions are expected to accelerate product development and clinical validation. The rise of e-commerce and digital health platforms also offers an attractive distribution channel, especially for reaching rural and underserved populations. Furthermore, increased focus on personalized medicine and patient-centric approaches could drive demand for customized pain relief solutions in the coming years.

Key Questions Answered in the Report:

  • What are the primary factors driving the global pain relief patches market's growth?
  • Which product types and indications are witnessing the highest adoption rates?
  • How are innovations in transdermal drug delivery impacting market trends?
  • Who are the leading players in the market, and what strategies are they implementing to enhance market share?
  • What are the emerging market trends and future projections for pain relief patches globally?

Competitive Intelligence and Business Strategy:

Leading companies in the global pain relief patches market, including Viatris, Inc. (Mylan), Johnson & Johnson Services, Inc., Teva Pharmaceutical Industries Ltd., Sanofi S.A., Hisamitsu Pharmaceutical Co., Inc., and GlaxoSmithKline Plc., are actively investing in research and development to enhance patch effectiveness, comfort, and drug delivery mechanisms. Strategic collaborations with healthcare providers and expansion into untapped regions are key focus areas. Players are also engaging in regulatory compliance and quality assurance efforts to build consumer trust and ensure consistent product performance. Emphasis on product differentiation through novel ingredients such as lidocaine, fentanyl, and capsaicin continues to shape competitive dynamics.

Companies Covered in This Report:

  • Viatris, Inc. (Mylan)
  • Johnson & Johnson Services, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Sanofi S.A.
  • Hisamitsu Pharmaceutical Co., Inc.
  • GlaxoSmithKline Plc.
  • Novartis AG
  • Nichiban Co., Ltd.
  • Teikoku Seiyaku Co., Ltd.
  • Mentholatum Company
  • Purdue Pharma L.P.
  • West-Ward Pharmaceuticals Corporation
  • Pfizer, Inc.
  • Allergan PLC (Actavis)

Market Segmentation:

By Product Type:

  • Non-steroidal Anti-inflammatory Drug Patches
  • Opioid Patches
  • Local Anesthetic Patches
  • Nitroglycerine Patches
  • Capsaicin Patches
  • Lidocaine Patches

By Indication:

  • Menstrual Cramps
  • Orthopedic Pain
  • Neuropathic Pain
  • Post-operative Pain
  • Cardiovascular Pain
  • Others

By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia and Oceania
  • Middle East and Africa
Product Code: PMRREP33349

Table of Contents

1. Executive Summary

  • 1.1. Global Pain Relief Patches Market Snapshot, 2025-2032
  • 1.2. Market Opportunity Assessment, 2025-2032, US$ Bn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overviews

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Challenges
    • 2.2.5. Key Trends
  • 2.3. Macro-Economic Factors
    • 2.3.1. Global Sectorial Outlook
    • 2.3.2. Global GDP Growth Outlook
    • 2.3.3. Global Healthcare Spending Outlook
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

  • 3.1. Drug Adoption Analysis
  • 3.2. Value Chain Analysis
    • 3.2.1. List of End-user/Marketplaces
      • 3.2.1.1. Retail
      • 3.2.1.2. E-commerce
    • 3.2.2. List of Indication (Industry)
  • 3.3. Key Deals and Mergers
  • 3.4. PESTLE Analysis
  • 3.5. Porter's Five Force Analysis

4. Global Pain Relief Patches Market Outlook

  • 4.1. Key Highlights
    • 4.1.1. Market Size (US$ Bn) and Y-o-Y Growth
    • 4.1.2. Absolute $ Opportunity
  • 4.2. Market Size (US$ Bn) Analysis and Forecast
    • 4.2.1. Historical Market Size (US$ Bn) Analysis, 2019-2024
    • 4.2.2. Current Market Size (US$ Bn) Analysis and Forecast, 2025-2032
  • 4.3. Global Pain Relief Patches Market Outlook: Product Type
    • 4.3.1. Introduction / Key Findings
    • 4.3.2. Historical Market Size (US$ Bn) Analysis, By Product Type, 2019-2024
    • 4.3.3. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
      • 4.3.3.1. Non-steroidal Anti-inflammatory Drug Patches
        • 4.3.3.1.1. Ketoprofen Patches
        • 4.3.3.1.2. Diclofenac Patches
        • 4.3.3.1.3. Flurbiprofen Patches
        • 4.3.3.1.4. Piroxicam Patches
      • 4.3.3.2. Opioid Patches
        • 4.3.3.2.1. Fentanyl Patches
        • 4.3.3.2.2. Buprenorphine Patches
      • 4.3.3.3. Local Anesthetic Patches
        • 4.3.3.3.1. Nitroglycerine Patches
        • 4.3.3.3.2. Capsaicin Patches
        • 4.3.3.3.3. Lidocaine Patches
    • 4.3.4. Market Attractiveness Analysis: Product Type
  • 4.4. Global Pain Relief Patches Market Outlook: Indication
    • 4.4.1. Introduction / Key Findings
    • 4.4.2. Historical Market Size (US$ Bn) Analysis, By Indication, 2019-2024
    • 4.4.3. Current Market Size (US$ Bn) Analysis and Forecast, By Indication, 2025-2032
      • 4.4.3.1. Menstrual Cramps
      • 4.4.3.2. Orthopedic Pain
      • 4.4.3.3. Neuropathic Pain
      • 4.4.3.4. Post-operative Pain
      • 4.4.3.5. Cardiovascular Pain
      • 4.4.3.6. Others
    • 4.4.4. Market Attractiveness Analysis: Indication
  • 4.5. Global Pain Relief Patches Market Outlook: Distribution Channel
    • 4.5.1. Introduction / Key Findings
    • 4.5.2. Historical Market Size (US$ Bn) Analysis, By Distribution Channel, 2019-2024
    • 4.5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025-2032
      • 4.5.3.1. Hospital Pharmacies
      • 4.5.3.2. Retail Pharmacies
      • 4.5.3.3. Online Pharmacies
    • 4.5.4. Market Attractiveness Analysis: Distribution Channel

5. Global Pain Relief Patches Market Outlook: Region

  • 5.1. Key Highlights
  • 5.2. Historical Market Size (US$ Bn) Analysis, By Region, 2019-2024
  • 5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Region, 2025-2032
    • 5.3.1. North America
    • 5.3.2. Europe
    • 5.3.3. East Asia
    • 5.3.4. South Asia and Oceania
    • 5.3.5. Latin America
    • 5.3.6. Middle East & Africa
  • 5.4. Market Attractiveness Analysis: Region

6. North America Pain Relief Patches Market Outlook

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 6.2.1. By Country
    • 6.2.2. By Product Type
    • 6.2.3. By Indication
    • 6.2.4. By Distribution Channel
  • 6.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 6.3.1. U.S.
    • 6.3.2. Canada
  • 6.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
    • 6.4.1. Permanent
    • 6.4.2. Contract Basis
  • 6.5. Market Attractiveness Analysis

7. Europe Pain Relief Patches Market Outlook

  • 7.1. Key Highlights
  • 7.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 7.2.1. By Country
    • 7.2.2. By Product Type
  • 7.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 7.3.1. Germany
    • 7.3.2. France
    • 7.3.3. U.K.
    • 7.3.4. Italy
    • 7.3.5. Spain
    • 7.3.6. Russia
    • 7.3.7. Turkey
    • 7.3.8. Rest of Europe
  • 7.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
    • 7.4.1. Non-steroidal Anti-inflammatory Drug Patches
      • 7.4.1.1. Ketoprofen Patches
      • 7.4.1.2. Diclofenac Patches
      • 7.4.1.3. Flurbiprofen Patches
      • 7.4.1.4. Piroxicam Patches
    • 7.4.2. Opioid Patches
      • 7.4.2.1. Fentanyl Patches
      • 7.4.2.2. Buprenorphine Patches
    • 7.4.3. Local Anesthetic Patches
      • 7.4.3.1. Nitroglycerine Patches
      • 7.4.3.2. Capsaicin Patches
      • 7.4.3.3. Lidocaine Patches
  • 7.5. Current Market Size (US$ Bn) Analysis and Forecast, By Indication, 2025-2032
    • 7.5.1. Menstrual Cramps
    • 7.5.2. Orthopedic Pain
    • 7.5.3. Neuropathic Pain
    • 7.5.4. Post-operative Pain
    • 7.5.5. Cardiovascular Pain
    • 7.5.6. Others
  • 7.6. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025-2032
    • 7.6.1. Hospital Pharmacies
    • 7.6.2. Retail Pharmacies
    • 7.6.3. Online Pharmacies
  • 7.7. Market Attractiveness Analysis

8. East Asia Pain Relief Patches Market Outlook

  • 8.1. Key Highlights
  • 8.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 8.2.1. By Country
    • 8.2.2. By Product Type
    • 8.2.3. By Indication
    • 8.2.4. By Distribution Channel
  • 8.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 8.3.1. China
    • 8.3.2. Japan
    • 8.3.3. South Korea
  • 8.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
    • 8.4.1. Non-steroidal Anti-inflammatory Drug Patches
      • 8.4.1.1. Ketoprofen Patches
      • 8.4.1.2. Diclofenac Patches
      • 8.4.1.3. Flurbiprofen Patches
      • 8.4.1.4. Piroxicam Patches
    • 8.4.2. Opioid Patches
      • 8.4.2.1. Fentanyl Patches
      • 8.4.2.2. Buprenorphine Patches
    • 8.4.3. Local Anesthetic Patches
      • 8.4.3.1. Nitroglycerine Patches
      • 8.4.3.2. Capsaicin Patches
      • 8.4.3.3. Lidocaine Patches
  • 8.5. Current Market Size (US$ Bn) Analysis and Forecast, By Indication, 2025-2032
    • 8.5.1. Menstrual Cramps
    • 8.5.2. Orthopedic Pain
    • 8.5.3. Neuropathic Pain
    • 8.5.4. Post-operative Pain
    • 8.5.5. Cardiovascular Pain
    • 8.5.6. Others
  • 8.6. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025-2032
    • 8.6.1. Hospital Pharmacies
    • 8.6.2. Retail Pharmacies
    • 8.6.3. Online Pharmacies
  • 8.7. Market Attractiveness Analysis

9. South Asia and Oceania Pain Relief Patches Market Outlook

  • 9.1. Key Highlights
  • 9.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 9.2.1. By Country
    • 9.2.2. By Product Type
    • 9.2.3. By Indication
    • 9.2.4. By Distribution Channel
  • 9.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 9.3.1. India
    • 9.3.2. Southeast Asia
    • 9.3.3. ANZ
    • 9.3.4. Rest of South Asia & Oceania
  • 9.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
    • 9.4.1. Non-steroidal Anti-inflammatory Drug Patches
      • 9.4.1.1. Ketoprofen Patches
      • 9.4.1.2. Diclofenac Patches
      • 9.4.1.3. Flurbiprofen Patches
      • 9.4.1.4. Piroxicam Patches
    • 9.4.2. Opioid Patches
      • 9.4.2.1. Fentanyl Patches
      • 9.4.2.2. Buprenorphine Patches
    • 9.4.3. Local Anesthetic Patches
      • 9.4.3.1. Nitroglycerine Patches
      • 9.4.3.2. Capsaicin Patches
      • 9.4.3.3. Lidocaine Patches
  • 9.5. Current Market Size (US$ Bn) Analysis and Forecast, By Indication, 2025-2032
    • 9.5.1. Menstrual Cramps
    • 9.5.2. Orthopedic Pain
    • 9.5.3. Neuropathic Pain
    • 9.5.4. Post-operative Pain
    • 9.5.5. Cardiovascular Pain
    • 9.5.6. Others
  • 9.6. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025-2032
    • 9.6.1. Hospital Pharmacies
    • 9.6.2. Retail Pharmacies
    • 9.6.3. Online Pharmacies
  • 9.7. Market Attractiveness Analysis

10. Latin America Pain Relief Patches Market Outlook

  • 10.1. Key Highlights
  • 10.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 10.2.1. By Country
    • 10.2.2. By Product Type
    • 10.2.3. By Indication
    • 10.2.4. By Distribution Channel
  • 10.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 10.3.1. Brazil
    • 10.3.2. Mexico
    • 10.3.3. Rest of Latin America
  • 10.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
    • 10.4.1. Non-steroidal Anti-inflammatory Drug Patches
      • 10.4.1.1. Ketoprofen Patches
      • 10.4.1.2. Diclofenac Patches
      • 10.4.1.3. Flurbiprofen Patches
      • 10.4.1.4. Piroxicam Patches
    • 10.4.2. Opioid Patches
      • 10.4.2.1. Fentanyl Patches
      • 10.4.2.2. Buprenorphine Patches
    • 10.4.3. Local Anesthetic Patches
      • 10.4.3.1. Nitroglycerine Patches
      • 10.4.3.2. Capsaicin Patches
      • 10.4.3.3. Lidocaine Patches
  • 10.5. Current Market Size (US$ Bn) Analysis and Forecast, By Indication, 2025-2032
    • 10.5.1. Menstrual Cramps
    • 10.5.2. Orthopedic Pain
    • 10.5.3. Neuropathic Pain
    • 10.5.4. Post-operative Pain
    • 10.5.5. Cardiovascular Pain
    • 10.5.6. Others
  • 10.6. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025-2032
    • 10.6.1. Hospital Pharmacies
    • 10.6.2. Retail Pharmacies
    • 10.6.3. Online Pharmacies
  • 10.7. Market Attractiveness Analysis

11. Middle East & Africa Pain Relief Patches Market Outlook

  • 11.1. Key Highlights
  • 11.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 11.2.1. By Country
    • 11.2.2. By Product Type
    • 11.2.3. By Indication
    • 11.2.4. By Distribution Channel
  • 11.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 11.3.1. GCC Countries
    • 11.3.2. Egypt
    • 11.3.3. South Africa
    • 11.3.4. Northern Africa
    • 11.3.5. Rest of Middle East & Africa
  • 11.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
    • 11.4.1. Non-steroidal Anti-inflammatory Drug Patches
      • 11.4.1.1. Ketoprofen Patches
      • 11.4.1.2. Diclofenac Patches
      • 11.4.1.3. Flurbiprofen Patches
      • 11.4.1.4. Piroxicam Patches
    • 11.4.2. Opioid Patches
      • 11.4.2.1. Fentanyl Patches
      • 11.4.2.2. Buprenorphine Patches
    • 11.4.3. Local Anesthetic Patches
      • 11.4.3.1. Nitroglycerine Patches
      • 11.4.3.2. Capsaicin Patches
      • 11.4.3.3. Lidocaine Patches
  • 11.5. Current Market Size (US$ Bn) Analysis and Forecast, By Indication, 2025-2032
    • 11.5.1. Menstrual Cramps
    • 11.5.2. Orthopedic Pain
    • 11.5.3. Neuropathic Pain
    • 11.5.4. Post-operative Pain
    • 11.5.5. Cardiovascular Pain
    • 11.5.6. Others
  • 11.6. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025-2032
    • 11.6.1. Hospital Pharmacies
    • 11.6.2. Retail Pharmacies
    • 11.6.3. Online Pharmacies
  • 11.7. Market Attractiveness Analysis

12. Competition Landscape

  • 12.1. Market Share Analysis, 2025
  • 12.2. Market Structure
    • 12.2.1. Competition Intensity Mapping by Market
    • 12.2.2. Competition Dashboard
  • 12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 12.3.1. Viatris, Inc. (Mylan)
      • 12.3.1.1. Overview
      • 12.3.1.2. Segments and Products
      • 12.3.1.3. Key Financials
      • 12.3.1.4. Market Developments
      • 12.3.1.5. Market Strategy
    • 12.3.2. Johnson & Johnson Services, Inc.
    • 12.3.3. Teva Pharmaceutical Industries Ltd.
    • 12.3.4. Sanofi S.A.
    • 12.3.5. Hisamitsu Pharmaceutical Co., Inc.
    • 12.3.6. GlaxoSmithKline Plc.
    • 12.3.7. Novartis AG
    • 12.3.8. Nichiban Co., Ltd.
    • 12.3.9. Teikoku Seiyaku Co, Ltd.
    • 12.3.10. Mentholatum Company
    • 12.3.11. Purdue Pharma L.P.
    • 12.3.12. West-Ward Pharmaceuticals Corporation
    • 12.3.13. Pfizer, Inc
    • 12.3.14. Allergan PLC (Actavis)
    • 12.3.15. Endo International PLC
    • 12.3.16. Mylan N.V.
    • 12.3.17. Corium, Inc.
    • 12.3.18. Agile Therapeutics Inc.

13. Appendix

  • 13.1. Research Methodology
  • 13.2. Research Assumptions
  • 13.3. Acronyms and Abbreviations
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!